Suchergebnisse - "Kow, Chia Siang"

PubPharm (269)

101

The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis

enthalten in: Inflammopharmacology | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

102

IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?

enthalten in: Cytokine | 2022

von Kow, C. | Zaihan, A. | Ramachandram, D. | +1

103

Statin use in patients with diabetes amid COVID-19 pandemic

enthalten in: Diabetes & metabolism | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Diabetes Metab. 2021 Mar;47(2):101202. - PMID 33091555

104

Metformin in COVID-19: clinical trials are needed to prove its benefits

enthalten in: Irish journal of medical science | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

105

Metformin in COVID-19: clinical trials are needed to prove its benefits

enthalten in: Irish journal of medical science | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

106

Physiological plausibility of lower viral load in patients with COVID‐19 and olfactory/gustatory dysfunction

enthalten in: Clinical Otolaryngology | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

107

The use of tenofovir in patients with COVID‐19

enthalten in: HIV Medicine | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

108

The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID‐19 : A meta‐analysis of randomized trials

enthalten in: Immunity, Inflammation and Disease | 2022

von Kow, C. | Lee, L. | Ramachandram, D. | +3

109

The effect of curcumin on the risk of mortality in patients with COVID‐19 : A systematic review and meta‐analysis of randomized trials

enthalten in: Phytotherapy Research | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

110

Future of antivirals in COVID-19 : The case of favipiravir

enthalten in: International immunopharmacology | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.